KARYOPHARM THERAPEUTICS INC's ticker is KPTI and the CUSIP is 48576U106. A total of 122 filers reported holding KARYOPHARM THERAPEUTICS INC in Q3 2018. The put-call ratio across all filers is 4.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $1,504,000 | -37.8% | 143,000 | -8.5% | 0.00% | -50.0% |
Q4 2020 | $2,418,000 | +4.0% | 156,227 | -1.9% | 0.00% | 0.0% |
Q3 2020 | $2,325,000 | -21.7% | 159,227 | +1.6% | 0.00% | -33.3% |
Q2 2020 | $2,969,000 | +16.3% | 156,782 | +18.0% | 0.00% | 0.0% |
Q1 2020 | $2,553,000 | -56.3% | 132,897 | -56.4% | 0.00% | -40.0% |
Q4 2019 | $5,846,000 | +234.8% | 304,940 | +68.0% | 0.01% | +150.0% |
Q3 2019 | $1,746,000 | +82.1% | 181,500 | +13.4% | 0.00% | +100.0% |
Q2 2019 | $959,000 | -0.9% | 160,100 | -3.4% | 0.00% | 0.0% |
Q1 2019 | $968,000 | -37.7% | 165,746 | 0.0% | 0.00% | -50.0% |
Q4 2018 | $1,553,000 | +170.1% | 165,746 | +391.0% | 0.00% | +100.0% |
Q3 2018 | $575,000 | +69.6% | 33,760 | +69.0% | 0.00% | – |
Q2 2018 | $339,000 | +45.5% | 19,971 | +299.4% | 0.00% | – |
Q2 2014 | $233,000 | +108.0% | 5,000 | 0.0% | 0.00% | – |
Q4 2013 | $112,000 | – | 5,000 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Palo Alto Investors LP | 3,200,396 | $30,084,000 | 1.72% |
TFS CAPITAL LLC | 105,040 | $987,000 | 0.26% |
Tekla Capital Management LLC | 500,324 | $4,703,000 | 0.20% |
Piermont Capital Management Inc. | 51,080 | $480,000 | 0.11% |
ESSEX INVESTMENT MANAGEMENT CO LLC | 55,793 | $524,000 | 0.09% |
Candriam S.C.A. | 390,000 | $3,666,000 | 0.08% |
Virtus ETF Advisers LLC | 27,446 | $258,000 | 0.08% |
SECOR Capital Advisors, LP | 66,484 | $625,000 | 0.08% |
Trexquant Investment LP | 29,007 | $273,000 | 0.04% |
PRELUDE CAPITAL MANAGEMENT, LLC | 32,196 | $303,000 | 0.04% |